Company Description
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally.
The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments.
It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions.
Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions.
The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013.
Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
| Country | Netherlands |
| Founded | 1891 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 69,656 |
| CEO | Roy Jakobs |
Contact Details
Address: Breitner Center, Amstelplein 2 Amsterdam, P7 1096 BC Netherlands | |
| Phone | 31 20 59 77777 |
| Website | philips.com |
Stock Details
| Ticker Symbol | PHG |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000313216 |
| CUSIP Number | 500472303 |
| ISIN Number | US5004723038 |
| SIC Code | 3844 |
Key Executives
| Name | Position |
|---|---|
| Roy Jakobs | President, Chief Executive Officer and Chairman of the Board of Management |
| Dr. Paulus A. Stoffels M.D., Ph.D. | Independent Vice Chairman of Supervisory Board and Secretary |
| Abhijit Bhattacharya | Executive Vice President, Chief Financial Officer and Member of the Board of Management |
| Marnix J. van Ginneken | Executive Vice President, Chief ESG, Legal Officer and Member of the Board of Management |
| Willem Appelo | Executive Vice President and Chief Operating Officer |
| Leandro Mazzoni | Head of Investor Relations |
| Heidi Sichien | Executive Vice President and Chief People Officer |
| Andy Ho | Executive Vice President and Chief Market Leader of Philips Greater China |
| Jan Kimpen | Chief Medical Officer |
| Pim Preesman | Country Leader/ Health Systems Leader Indonesia |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 22, 2024 | 6-K | Report of foreign issuer |
| Feb 28, 2024 | 6-K | Report of foreign issuer |
| Feb 20, 2024 | 6-K | Report of foreign issuer |
| Feb 20, 2024 | 6-K | Report of foreign issuer |
| Feb 20, 2024 | 20-F | Annual and transition report of foreign private issuers |
| Feb 6, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jan 29, 2024 | 6-K | Report of foreign issuer |
| Dec 20, 2023 | 6-K | Report of foreign issuer |
| Oct 23, 2023 | 6-K | Report of foreign issuer |
| Sep 7, 2023 | 6-K | Report of foreign issuer |